Publications by authors named "Gozewijn D Laverman"

Claim this Profile
T
Towards vitality: a longitudinal pilot study with a cognitive bias modification e-health intervention (VitalMe) to reduce fatigue in patients with chronic kidney disease.
Jody A Geerts, Christina Bode, Elske Salemink, Gozewijn D Laverman, Femke Waanders

Health Psychol Behav Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
User Experiences of a Bihormonal Fully Closed-Loop System Among Adults with Type 1 Diabetes in a Real-World Setting: A Qualitative Analysis.
Giesje Nefs, Theodorus J P Jansen, Michel Klaassen, Lyan B Vlaskamp, Mattijs Out, Gozewijn D Laverman

Diabetes Technol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DIABASE: an automatically filled single-centre registry of diabetes mellitus in the Netherlands, combining clinical data with real-world longitudinal wearable device data-a study protocol.
Thomas Urgert, Kilian Derk Rinse Kappert, Anouk Veldhuis, Jeroen Geerdink, Bernard Johannes Frederik van Beijnum, Gozewijn Dirk Laverman

BMJ Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments in albuminuria testing: A key biomarker for detection, prognosis and surveillance of kidney and cardiovascular disease-A practical update for clinicians.
Jelle M Beernink, Dominique van Mil, Gozewijn D Laverman, Hiddo J L Heerspink, Ron T Gansevoort

Diabetes Obes Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial.
Jelle M Beernink, Niels Jongs, Charlotte M Mosterd, Rosalie A Scholtes, Alyssa Caldwell-McGee, Gozewijn D Laverman

Diabetes Obes Metab· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Lifestyle Counselling Into Secondary Type 2 Diabetes Care: Perspectives From Diabetes Nurses.
Chantal H M Pot, Eclaire A G Hietbrink, Gozewijn D Laverman

Nurs Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial.
Jelle M Beernink, Niels Jongs, Cees J A Doelman, Gozewijn D Laverman, Hiddo J L Heerspink

JAMA Netw Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Acceptance of Just-in-Time Adaptive Lifestyle Support for People With Type 2 Diabetes: Qualitative Acceptability Study.
Eclaire A G Hietbrink, Anouk Middelweerd, Wendy d'Hollosy, Laura K Schrijver, Gozewijn D Laverman

JMIR Form Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of the relation between continuous glucose monitoring observation period and the estimation error in assessing long-term glucose regulation.
Stennie Zoet, Thomas Urgert, Anouk Veldhuis, Bert-Jan van Beijnum, Gozewijn D Laverman

BMJ Open Diabetes Res Care· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial.
Ellen M Apperloo, Jose L Gorriz, Maria Jose Soler, Secundino Cigarrán Guldris, Josep M Cruzado, Gozewijn D Laverman

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysing physical activity measures and clustering in patients with type 2 diabetes in secondary care: insights from the DIAbetes and LifEstyle Cohort Twente (DIALECT)-an observational cohort study.
Niala den Braber, Miriam M Vollenbroek-Hutten, Kilian D R Kappert, Gozewijn D Laverman

BMJ Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Contribution of Postprandial Glucose Levels to Hyperglycemia in Type 2 Diabetes Calculated from Continuous Glucose Monitoring Data: Real World Evidence from the DIALECT-2 Cohort.
Niala den Braber, Miriam M R Vollenbroek-Hutten, Sacha E M Teunissen, Milou M Oosterwijk, Kilian D R Kappert, Gozewijn D Laverman

Nutrients· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a diagnostic Puumala virus real-time RT-PCR in an orthohantavirus endemic region in the Netherlands.
Felix Geeraedts, Mariska Wevers, Froukje Bosma, Maria de Boer, J N Brinkman, Gozewijn D Laverman

Microbiol Spectr· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences of Data Loss on Clinical Decision-Making in Continuous Glucose Monitoring: Retrospective Cohort Study.
Niala den Braber, Carlijn I R Braem, Miriam M R Vollenbroek-Hutten, Hermie J Hermens, Thomas Urgert, Gozewijn D Laverman

Interact J Med Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum T predicts cardiovascular mortality in individuals with type 2 diabetes: A prospective cohort study.
Amarens van der Vaart, Coby Eelderink, Harry van Goor, Jan-Luuk Hillebrands, Charlotte A Te Velde-Keyzer, Gozewijn D Laverman

J Intern Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Post-Translationally Modified Fetuin-A Protein Is Associated with Increased Risk of Graft Failure in Kidney Transplant Recipients.
Firas F Alkaff, Daan Kremer, Charlotte A Te Velde-Keyzer, Jacob van den Born, Stefan P Berger, Gozewijn D Laverman

Am J Nephrol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary Fetuin-A Fragments Predict Progressive Estimated Glomerular Filtration Rate Decline in Two Independent Type 2 Diabetes Cohorts of Different Ethnicities.
Gwo-Tsann Chuang, Daan Kremer, Chi-Hsuan Huang, Firas F Alkaff, Chih-Hung Lin, Gozewijn D Laverman

Am J Nephrol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NT-proBNP Mediates the Association Between FGF23 and All-Cause Mortality in Individuals With Type 2 Diabetes.
Amarens van der Vaart, Stephan J L Bakker, Gozewijn D Laverman, Peter R van Dijk, Martin H de Borst

J Am Heart Assoc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
Viktor Rotbain Curovic, Morten B Houlind, Marjolein Y A M Kroonen, Niels Jongs, Emilie H Zobel, Gozewijn D Laverman

Diabetes Obes Metab· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial.
Jens Christian Laursen, Viktor Rotbain Curovic, Marjolein Y A M Kroonen, Niels Jongs, Emilie H Zobel, Gozewijn D Laverman

Diabetes Obes Metab· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials.
Taha Sen, Viktor Rotbain Curovic, Niels Jongs, Gozewijn D Laverman, Adriaan Kooy

Diabetes Obes Metab· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Digital Coach (E-Supporter 1.0) to Support Physical Activity and a Healthy Diet in People With Type 2 Diabetes: Acceptability and Limited Efficacy Testing.
Eclaire A G Hietbrink, Wendy Oude Nijeweme-d'Hollosy, Anouk Middelweerd, Annemieke A J Konijnendijk, Laura K Schrijver, Gozewijn D Laverman

JMIR Form Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial.
Viktor Rotbain Curovic, Niels Jongs, Marjolein Y A M Kroonen, Emilie H Zobel, Tine W Hansen, Gozewijn D Laverman

Diabetes Care· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study.
Jelle M Beernink, Frederik Persson, Niels Jongs, Gozewijn D Laverman, Glenn M Chertow

Diabetes Care· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY.
Nicole Oosterom, Niala den Braber, Gozewijn D Laverman

Endocrinol Diabetes Metab Case Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis